Lavender oil aromatherapy associated with pain, anxiety and hemodynamic parameters in patients after coronary artery bypass grafting surgery.
Conditions
Interventions
Intervention 1: In the intervention group 5 drops of Lavandula oil 100% will rub on the upper lips of patient (the distance between the nose and lips) and would be inhaled in 30 minutes by the patient
In the intervention group 5 drops of Lavandula oil 100% will rub on the upper lips of patient (the distance between the nose and lips) and would be inhaled in 30 minutes by the patient. Intervention w
In the placebo group 5 drops of distilled water will rub on the upper lips of patient (the distance between the nose and lips) and would be inhaled in 30 minutes by the patient. Intervention will be d
Sponsors
Guilan University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 139 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: admitted for coronary artery bypass surgery in cardiac surgery ward at Dr. Heshmat Educational and Medical Center in Rasht; patients over 18 years old; without history of drugs affecting on neurological system based on documents; without smell and visual disorders based on commenting of patient; without history of pulmonary diseases, hepatitis, diabetes, chronic headaches, migraines and psychological disorder; without history thyroid diseases (based on documents); without history of cardiac surgery; tendency to collaboration; without history of drugs abuse, smoking and alcohol (based on documents); orientation; without history of allergies, contact dermatitis and sensitivity to plants, especially Lavandula and cosmetic fragrances; without acute diseases; without history of aromatherapy based on documents; bedridden in Intensive Care Unit under 72 hours; duration of intubation in the range of 6 to 8 hours in the Intensive Care Unit based on documents; not to use analgesic, antianxiety drugs, sedative and narcotics during 3 hours before starting of the study and having a systolic blood pressure of 95 mm Hg and upper than. Exclusion criteria: any sudden onset of severe changes in vital signs; onset of respiratory allergy signs and having a systolic blood pressure lower than 95 mm Hg at each stage of the research.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pain. Timepoint: Before the intervention and half hour after the intervention every 24 hours for three consecutive days. Method of measurement: Visual Analoge Scale.;Anxiety. Timepoint: Before the intervention and half hour after the intervention every 24 hours for three consecutive days. Method of measurement: Section of anxiety of the Hospital Anxiety and Depression Scale (HADS).;Diastolic and systolic blood pressure. Timepoint: Before the intervention and half hour after the intervention every 24 hours for three consecutive days. Method of measurement: By using a mercury sphygmomanometer based on mmHg.;Pulse. Timepoint: Before the intervention and half hour after the intervention every 24 hours for three consecutive days. Method of measurement: Based on the number of pulses in a minute.;Respiration. Timepoint: Before the intervention and half hour after the intervention every 24 hours for three consecutive days. Method of measurement: Based on the number of breaths in a minute. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactEzzat Paryad
Guilan University of Medical Sciences, Shahid Beheshti Nursing and Midwifery Faculty
Outcome results
None listed